Cargando…
Hypertriglyceridemia and Cardiovascular Diseases: Revisited
Residual cardiovascular risk and failure of high density lipoprotein cholesterol raising treatment have refocused interest on targeting hypertriglyceridemia. Hypertriglyceridemia, triglyceride-rich lipoproteins, and remnant cholesterol have demonstrated to be important risk factors for cardiovascula...
Autores principales: | Han, Seung Hwan, Nicholls, Stephen J, Sakuma, Ichiro, Zhao, Dong, Koh, Kwang Kon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805556/ https://www.ncbi.nlm.nih.gov/pubmed/27014342 http://dx.doi.org/10.4070/kcj.2016.46.2.135 |
Ejemplares similares
-
Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events
por: Koh, Kwang Kon, et al.
Publicado: (2017) -
Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia
por: Mszar, Reed, et al.
Publicado: (2023) -
Combination Pravastatin and Valsartan Treatment Has Additive Beneficial Effects to Simultaneously Improve Both Metabolic and Cardiovascular Phenotypes Beyond That of Monotherapy With Either Drug in Patients With Primary Hypercholesterolemia
por: Koh, Kwang Kon, et al.
Publicado: (2013) -
The Novelty of Icosapent Ethyl in the Management of Hypertriglyceridemia and Alleviating Cardiovascular Risk
por: Khan, Muhammad Shoaib, et al.
Publicado: (2021) -
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis
por: Hernandez, Patricia, et al.
Publicado: (2021)